| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.733 | 0.006 | 0.733 | Aldehyde oxidase inhibitor | |||
| 0.713 | 0.003 | 0.713 | Alcohol oxidase inhibitor | 0.078 0.025 CID_154699703 | ||
| 0.702 | 0.005 | 0.702 | Amyloid beta aggregation inhibitor | 0.361 0.032 CID_154699703 | ||
| 0.695 | 0.002 | 0.695 | Tyrosine 3 hydroxylase inhibitor | 0.195 0.145 CID_154699703 | ||
| 0.635 | 0.003 | 0.635 | Sigma 1 receptor antagonist | |||
| 0.632 | 0.003 | 0.632 | Cystathionine beta-synthase inhibitor | 0.54 0.003 CID_154699703 | ||
| 0.589 | 0.005 | 0.589 | Peroxidase inhibitor | |||
| 0.589 | 0.009 | 0.589 | GABA C receptor rho-3 antagonist | |||
| 0.534 | 0.004 | 0.534 | Amyloid beta precursor protein antagonist | 0.168 0.083 CID_154699703 | ||
| 0.511 | 0.005 | 0.732 | Alpha-N-acetylglucosaminidase inhibitor | 0.732 0.003 CID_154699703 | CID_154699703 | |
| 0.492 | 0.004 | 0.492 | Sigma receptor antagonist | |||
| 0.544 | 0.062 | 0.704 | Apoptosis agonist | 0.704 0.03 CID_154699703 | CID_154699703 | |
| 0.512 | 0.031 | 0.711 | Cholesterol antagonist | 0.711 0.007 CID_154699703 | CID_154699703 | |
| 0.478 | 0.002 | 0.478 | Keratolytic | 0.123 0.021 CID_154699703 | ||
| 0.468 | 0.008 | 0.468 | Calcium channel activator | 0.278 0.115 CID_154699703 | ||
| 0.488 | 0.029 | 0.488 | 5 Hydroxytryptamine release stimulant | 0.279 0.077 CID_154699703 | ||
| 0.463 | 0.005 | 0.463 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.466 | 0.017 | 0.466 | Superoxide dismutase inhibitor | |||
| 0.446 | 0.003 | 0.446 | GABA aminotransferase inhibitor | 0.363 0.003 CID_154699703 | ||
| 0.449 | 0.007 | 0.449 | MAP kinase kinase 2 inhibitor | |||
| 0.446 | 0.008 | 0.446 | Sodium/bile acid cotransporter inhibitor | 0.351 0.039 CID_154699703 | ||
| 0.451 | 0.022 | 0.669 | Free radical scavenger | 0.669 0.006 CID_154699703 | CID_154699703 | |
| 0.428 | 0.021 | 0.428 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.453 | 0.05 | 0.525 | 5 Hydroxytryptamine release inhibitor | 0.525 0.025 CID_154699703 | CID_154699703 | |
| 0.405 | 0.004 | 0.405 | Estrogen antagonist | |||
| 0.392 | 0.003 | 0.619 | Triose-phosphate isomerase inhibitor | 0.619 0.002 CID_154699703 | CID_154699703 | |
| 0.414 | 0.025 | 0.442 | DNA damaging | 0.442 0.02 CID_154699703 | CID_154699703 | |
| 0.404 | 0.019 | 0.404 | Pyruvate kinase inhibitor | |||
| 0.398 | 0.019 | 0.398 | Transcription factor STAT inhibitor | 0.192 0.15 CID_154699703 | ||
| 0.38 | 0.004 | 0.38 | Alcohol dehydrogenase inhibitor | 0.291 0.005 CID_154699703 | ||
| 0.455 | 0.08 | 0.455 | Caspase 9 stimulant | 0.432 0.093 CID_154699703 | ||
| 0.376 | 0.004 | 0.376 | Estrogen receptor beta antagonist | |||
| 0.376 | 0.006 | 0.376 | Aldehyde dehydrogenase inhibitor | 0.329 0.009 CID_154699703 | ||
| 0.396 | 0.027 | 0.396 | Dyrk kinase inhibitor | |||
| 0.424 | 0.058 | 0.723 | Transcription factor NF kappa B inhibitor | 0.723 0.018 CID_154699703 | CID_154699703 | |
| 0.369 | 0.006 | 0.369 | GABA C receptor agonist | 0.094 0.073 CID_154699703 | ||
| 0.366 | 0.003 | 0.366 | Creatine kinase inhibitor | 0.088 0.075 CID_154699703 | ||
| 0.375 | 0.019 | 0.375 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.358 | 0.004 | 0.358 | Porphobilinogen synthase inhibitor | |||
| 0.358 | 0.004 | 0.358 | NMDA 2 receptor antagonist | |||
| 0.358 | 0.005 | 0.358 | MAP kinase kinase inhibitor | |||
| 0.354 | 0.006 | 0.354 | Interleukin 4 antagonist | 0.21 0.02 CID_154699703 | ||
| 0.353 | 0.005 | 0.353 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.351 | 0.005 | 0.351 | Aminoacyl-tRNA synthetase inhibitor | 0.157 0.017 CID_154699703 | ||
| 0.346 | 0.004 | 0.359 | Mannose-6-phosphate isomerase inhibitor | 0.359 0.004 CID_154699703 | CID_154699703 | |
| 0.342 | 0.006 | 0.342 | CDC-like kinase 1 inhibitor | |||
| 0.34 | 0.005 | 0.34 | Carbonic anhydrase XV inhibitor | |||
| 0.358 | 0.029 | 0.514 | DNA synthesis inhibitor | 0.514 0.012 CID_154699703 | CID_154699703 | |
| 0.365 | 0.036 | 0.462 | Antiamyloidogenic | 0.462 0.02 CID_154699703 | CID_154699703 | |
| 0.406 | 0.077 | 0.406 | Calcium channel L-type activator | |||
| 0.329 | 0.005 | 0.329 | NMDA receptor antagonist | |||
| 0.333 | 0.009 | 0.479 | UDP-glucose 4-epimerase inhibitor | 0.479 0.003 CID_154699703 | CID_154699703 | |
| 0.337 | 0.013 | 0.504 | Protein kinase stimulant | 0.504 0.004 CID_154699703 | CID_154699703 | |
| 0.323 | 0.001 | 0.323 | NMDA 2D receptor antagonist | 0.095 0.004 CID_154699703 | ||
| 0.324 | 0.005 | 0.324 | Glutamate dehydrogenase inhibitor | 0.216 0.009 CID_154699703 | ||
| 0.397 | 0.077 | 0.499 | Histamine release inhibitor | 0.499 0.029 CID_154699703 | CID_154699703 | |
| 0.324 | 0.005 | 0.521 | ATPase inhibitor | 0.521 0.003 CID_154699703 | CID_154699703 | |
| 0.325 | 0.008 | 0.325 | Succinate dehydrogenase inhibitor | 0.182 0.066 CID_154699703 | ||
| 0.316 | 0.004 | 0.316 | MAP kinase kinase 5 inhibitor | 0.165 0.1 CID_154699703 | ||
| 0.389 | 0.082 | 0.681 | Antibacterial | 0.681 0.01 CID_154699703 | CID_154699703 | |
| 0.356 | 0.052 | 0.553 | Vasodilator, coronary | 0.553 0.01 CID_154699703 | CID_154699703 | |
| 0.316 | 0.016 | 0.316 | Protein-tyrosine phosphatase inhibitor | 0.233 0.036 CID_154699703 | ||
| 0.301 | 0.002 | 0.301 | D-Ala-D-Ala ligase inhibitor | 0.089 0.047 CID_154699703 | ||
| 0.3 | 0.003 | 0.3 | DOPA decarboxylase inhibitor | 0.12 0.045 CID_154699703 | ||
| 0.297 | 0.004 | 0.444 | Photosensitizer | 0.444 0.003 CID_154699703 | CID_154699703 | |
| 0.294 | 0.004 | 0.294 | Transcription factor STAT6 inhibitor | 0.105 0.092 CID_154699703 | ||
| 0.337 | 0.05 | 0.691 | Antioxidant | 0.691 0.006 CID_154699703 | CID_154699703 | |
| 0.289 | 0.011 | 0.289 | Glutamate receptor antagonist | |||
| 0.272 | 0.004 | 0.272 | NMDA 2C receptor antagonist | |||
| 0.268 | 0.004 | 0.268 | NMDA receptor subunit 3B antagonist | |||
| 0.273 | 0.01 | 0.273 | Ferrochelatase inhibitor | |||
| 0.26 | 0.004 | 0.26 | NMDA receptor subunit 3A antagonist | |||
| 0.275 | 0.019 | 0.275 | Nitric-oxide synthase stimulant | 0.273 0.02 CID_154699703 | ||
| 0.26 | 0.004 | 0.26 | Interleukin 12 antagonist | 0.19 0.006 CID_154699703 | ||
| 0.377 | 0.122 | 0.377 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.29 | 0.039 | 0.29 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.264 | 0.013 | 0.264 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.253 | 0.006 | 0.253 | Estrogen agonist | 0.068 0.027 CID_154699703 | ||
| 0.27 | 0.023 | 0.582 | Amylase inhibitor | 0.582 0.004 CID_154699703 | CID_154699703 | |
| 0.391 | 0.144 | 0.837 | Antiinflammatory | 0.837 0.011 CID_154699703 | CID_154699703 | |
| 0.25 | 0.004 | 0.25 | NMDA 2A receptor antagonist | |||
| 0.263 | 0.018 | 0.263 | Adenylate cyclase inhibitor | 0.164 0.037 CID_154699703 | ||
| 0.247 | 0.003 | 0.247 | Purinergic P2X2 antagonist | 0.126 0.019 CID_154699703 | ||
| 0.316 | 0.075 | 0.574 | Apoptosis antagonist | 0.574 0.012 CID_154699703 | CID_154699703 | |
| 0.245 | 0.005 | 0.245 | MAP3K9 inhibitor | |||
| 0.24 | 0.004 | 0.24 | CDK4/cyclin D1 inhibitor | |||
| 0.238 | 0.003 | 0.238 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.268 | 0.035 | 0.268 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.191 0.081 CID_154699703 | ||
| 0.295 | 0.068 | 0.331 | Hypoxia-inducible factor 1 alpha inhibitor | 0.331 0.052 CID_154699703 | CID_154699703 | |
| 0.232 | 0.005 | 0.232 | Thioredoxin inhibitor | 0.212 0.007 CID_154699703 | ||
| 0.243 | 0.017 | 0.243 | Chelator | |||
| 0.297 | 0.071 | 0.41 | Spasmolytic | 0.41 0.038 CID_154699703 | CID_154699703 | |
| 0.228 | 0.004 | 0.228 | Prostaglandin F2 alpha antagonist | 0.103 0.01 CID_154699703 | ||
| 0.231 | 0.007 | 0.231 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.245 | 0.022 | 0.245 | Heat shock protein 90 antagonist | |||
| 0.231 | 0.01 | 0.231 | Carbonic anhydrase VI inhibitor | 0.097 0.041 CID_154699703 | ||
| 0.278 | 0.058 | 0.851 | Angiogenesis stimulant | 0.851 0.003 CID_154699703 | CID_154699703 | |
| 0.253 | 0.037 | 0.259 | Neurotrophic factor enhancer | 0.259 0.034 CID_154699703 | CID_154699703 | |
| 0.221 | 0.004 | 0.221 | MAP kinase kinase 1 inhibitor | |||
| 0.23 | 0.016 | 0.23 | Cathepsin H inhibitor | 0.117 0.079 CID_154699703 | ||
| 0.225 | 0.012 | 0.32 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.32 0.005 CID_154699703 | CID_154699703 | |
| 0.229 | 0.017 | 0.229 | GABA C receptor rho-2 antagonist | |||
| 0.267 | 0.056 | 0.42 | Cyclic AMP phosphodiesterase inhibitor | 0.42 0.014 CID_154699703 | CID_154699703 | |
| 0.23 | 0.022 | 0.4 | Hexokinase inhibitor | 0.4 0.004 CID_154699703 | CID_154699703 | |
| 0.261 | 0.055 | 0.261 | Calpain inhibitor | |||
| 0.216 | 0.012 | 0.216 | Androgen antagonist | |||
| 0.216 | 0.013 | 0.216 | Adenylate kinase inhibitor | 0.171 0.02 CID_154699703 | ||
| 0.212 | 0.012 | 0.212 | Histidine decarboxylase inhibitor | |||
| 0.204 | 0.006 | 0.204 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.25 | 0.052 | 0.25 | Death-associated protein kinase 3 inhibitor | |||
| 0.228 | 0.031 | 0.228 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.201 | 0.005 | 0.201 | Myeloperoxidase inhibitor | |||
| 0.247 | 0.051 | 0.247 | RNA-directed DNA polymerase inhibitor | 0.21 0.086 CID_154699703 | ||
| 0.2 | 0.006 | 0.2 | Cyclin B3 inhibitor | |||
| 0.204 | 0.011 | 0.204 | Protein kinase C zeta inhibitor | |||
| 0.214 | 0.025 | 0.214 | Protein-tyrosine phosphatase 1B inhibitor | 0.201 0.029 CID_154699703 | ||
| 0.201 | 0.013 | 0.574 | Beta glucuronidase inhibitor | 0.574 0.003 CID_154699703 | CID_154699703 | |
| 0.211 | 0.024 | 0.211 | Arachidonic acid antagonist | 0.149 0.089 CID_154699703 | ||
| 0.195 | 0.011 | 0.396 | NADH dehydrogenase inhibitor | 0.396 0.005 CID_154699703 | CID_154699703 | |
| 0.266 | 0.082 | 0.266 | Insulysin inhibitor | |||
| 0.191 | 0.008 | 0.191 | Glutamate decarboxylase inhibitor | |||
| 0.196 | 0.014 | 0.196 | GABA C receptor antagonist | |||
| 0.215 | 0.033 | 0.215 | Tubulin antagonist | |||
| 0.194 | 0.015 | 0.201 | Carbonic anhydrase XIII inhibitor | 0.201 0.014 CID_154699703 | CID_154699703 | |
| 0.188 | 0.01 | 0.188 | Electrolyte absorption antagonist | |||
| 0.183 | 0.005 | 0.183 | Dopamine transporter inhibitor | |||
| 0.201 | 0.024 | 0.201 | Protein kinase (CK2) alpha inhibitor | |||
| 0.181 | 0.004 | 0.181 | Beta 3 adrenoreceptor antagonist | |||
| 0.187 | 0.011 | 0.187 | Dopamine D1 antagonist | |||
| 0.279 | 0.104 | 0.701 | Antithrombotic | 0.701 0.008 CID_154699703 | CID_154699703 | |
| 0.211 | 0.037 | 0.358 | Lipid peroxidase inhibitor | 0.358 0.012 CID_154699703 | CID_154699703 | |
| 0.191 | 0.018 | 0.191 | Adenylate cyclase stimulant | 0.136 0.089 CID_154699703 | ||
| 0.177 | 0.005 | 0.177 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.175 0.005 CID_154699703 | ||
| 0.181 | 0.009 | 0.181 | Adrenaline agonist | |||
| 0.218 | 0.047 | 0.218 | Histone acetyltransferase inhibitor | |||
| 0.176 | 0.005 | 0.176 | Estrogen receptor alpha agonist | |||
| 0.191 | 0.02 | 0.212 | Beta amyloid protein antagonist | 0.212 0.013 CID_154699703 | CID_154699703 | |
| 0.268 | 0.099 | 0.268 | 12-Lipoxygenase inhibitor | |||
| 0.177 | 0.009 | 0.177 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 CID_154699703 | ||
| 0.17 | 0.005 | 0.17 | Glycine receptor agonist | 0.147 0.007 CID_154699703 | ||
| 0.169 | 0.004 | 0.169 | ATPase (Vacuolar H+) inhibitor | 0.167 0.005 CID_154699703 | ||
| 0.186 | 0.022 | 0.186 | Protein kinase (CK2) inhibitor | |||
| 0.248 | 0.085 | 0.248 | Transcription factor STAT3 inhibitor | |||
| 0.164 | 0.003 | 0.164 | Glutamate (mGluR7) antagonist | 0.081 0.027 CID_154699703 | ||
| 0.176 | 0.015 | 0.176 | Caspase 3 inhibitor | 0.099 0.094 CID_154699703 | ||
| 0.168 | 0.008 | 0.168 | NMDA 2B receptor antagonist | |||
| 0.209 | 0.049 | 0.209 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.163 | 0.006 | 0.163 | CDK4/cyclin D inhibitor | |||
| 0.22 | 0.063 | 0.22 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.252 | 0.095 | 0.535 | Immunostimulant | 0.535 0.024 CID_154699703 | CID_154699703 | |
| 0.198 | 0.042 | 0.359 | Melanin inhibitor | 0.359 0.015 CID_154699703 | CID_154699703 | |
| 0.172 | 0.016 | 0.379 | DNA repair enzyme inhibitor | 0.379 0.003 CID_154699703 | CID_154699703 | |
| 0.186 | 0.031 | 0.186 | CF transmembrane conductance regulator agonist | 0.134 0.109 CID_154699703 | ||
| 0.159 | 0.004 | 0.159 | Glutamate (mGluR3) antagonist | 0.042 0.018 CID_154699703 | ||
| 0.166 | 0.011 | 0.166 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.083 0.058 CID_154699703 | ||
| 0.16 | 0.005 | 0.227 | Glycine receptor antagonist | 0.227 0.003 CID_154699703 | CID_154699703 | |
| 0.221 | 0.067 | 0.221 | Clk dual-specificity kinase inhibitor | |||
| 0.168 | 0.015 | 0.168 | GABA C receptor rho-1 antagonist | |||
| 0.163 | 0.01 | 0.163 | Histamine N-methyltransferase inhibitor | |||
| 0.201 | 0.049 | 0.201 | Heat shock protein 90 alpha antagonist | |||
| 0.173 | 0.022 | 0.173 | Carbonic anhydrase III inhibitor | 0.094 0.069 CID_154699703 | ||
| 0.166 | 0.015 | 0.29 | Phosphofructokinase-1 inhibitor | 0.29 0.006 CID_154699703 | CID_154699703 | |
| 0.154 | 0.004 | 0.154 | Sphingosine kinase 2 inhibitor | |||
| 0.166 | 0.016 | 0.166 | Prolactin inhibitor | |||
| 0.155 | 0.005 | 0.155 | Cyclin B2 inhibitor | |||
| 0.16 | 0.012 | 0.16 | Adenosine A3 receptor antagonist | 0.088 0.034 CID_154699703 | ||
| 0.178 | 0.03 | 0.178 | Farnesoid X receptor antagonist | |||
| 0.161 | 0.015 | 0.161 | Phosphodiesterase I inhibitor | |||
| 0.194 | 0.048 | 0.194 | Phospholipase C inhibitor | 0.165 0.079 CID_154699703 | ||
| 0.173 | 0.029 | 0.173 | Aminopeptidase B inhibitor | |||
| 0.168 | 0.024 | 0.168 | Vanilloid 1 agonist | 0.154 0.034 CID_154699703 | ||
| 0.153 | 0.009 | 0.153 | Adrenaline uptake inhibitor | |||
| 0.211 | 0.068 | 0.211 | Anesthetic general | 0.194 0.078 CID_154699703 | ||
| 0.184 | 0.041 | 0.184 | Nav1.2 sodium channel blocker | |||
| 0.147 | 0.005 | 0.147 | Phosphodiesterase 1C inhibitor | |||
| 0.154 | 0.013 | 0.154 | Somatostatin 1 agonist | |||
| 0.187 | 0.046 | 0.347 | Interferon gamma antagonist | 0.347 0.014 CID_154699703 | CID_154699703 | |
| 0.156 | 0.015 | 0.156 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.203 | 0.065 | 0.203 | CDC-like kinase 2 inhibitor | |||
| 0.175 | 0.037 | 0.175 | Toll-Like receptor 2 antagonist | |||
| 0.22 | 0.082 | 0.22 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.142 | 0.005 | 0.142 | Beta 2 adrenoreceptor antagonist | |||
| 0.145 | 0.007 | 0.145 | Estrogen receptor beta agonist | |||
| 0.146 | 0.01 | 0.146 | Biliverdin reductase inhibitor | 0.101 0.018 CID_154699703 | ||
| 0.141 | 0.007 | 0.141 | Beta adrenoreceptor antagonist | |||
| 0.14 | 0.005 | 0.14 | Beta 1 adrenoreceptor antagonist | |||
| 0.16 | 0.027 | 0.17 | Mucolytic | 0.17 0.022 CID_154699703 | CID_154699703 | |
| 0.197 | 0.064 | 0.197 | LIM domain kinase 1 inhibitor | |||
| 0.138 | 0.005 | 0.138 | Heat shock protein 90 beta antagonist | |||
| 0.138 | 0.006 | 0.138 | Cyclin B inhibitor | |||
| 0.154 | 0.022 | 0.154 | Breast cancer-resistant protein inhibitor | |||
| 0.14 | 0.008 | 0.14 | Phosphodiesterase 1B inhibitor | |||
| 0.135 | 0.005 | 0.135 | Estrogen-related receptor beta agonist | |||
| 0.173 | 0.043 | 0.173 | NADPH oxidase inhibitor | 0.124 0.078 CID_154699703 | ||
| 0.16 | 0.031 | 0.248 | Xanthine oxidase inhibitor | 0.248 0.012 CID_154699703 | CID_154699703 | |
| 0.145 | 0.016 | 0.145 | Macrophage migration inhibitory factor inhibitor | |||
| 0.146 | 0.017 | 0.146 | Carbonic anhydrase inhibitor | 0.14 0.018 CID_154699703 | ||
| 0.133 | 0.005 | 0.133 | 5 Hydroxytryptamine 7 agonist | |||
| 0.16 | 0.032 | 0.16 | MAP kinase 13 inhibitor | |||
| 0.177 | 0.05 | 0.177 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.146 | 0.02 | 0.146 | Anabolic | |||
| 0.178 | 0.052 | 0.178 | Neurotensin receptor agonist | |||
| 0.158 | 0.035 | 0.158 | Alpha 2b adrenoreceptor antagonist | |||
| 0.136 | 0.014 | 0.136 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.167 | 0.046 | 0.167 | MAP kinase 3 inhibitor | |||
| 0.149 | 0.029 | 0.17 | Falcipain 2 inhibitor | 0.17 0.021 CID_154699703 | CID_154699703 | |
| 0.151 | 0.031 | 0.173 | Falcipain inhibitor | 0.173 0.022 CID_154699703 | CID_154699703 | |
| 0.137 | 0.017 | 0.137 | Adenosine A1 receptor antagonist | 0.052 0.047 CID_154699703 | ||
| 0.122 | 0.003 | 0.122 | Dopamine D5 agonist | |||
| 0.153 | 0.034 | 0.153 | 5 Hydroxytryptamine 3A agonist | |||
| 0.269 | 0.15 | 0.269 | 15-Lipoxygenase inhibitor | |||
| 0.126 | 0.008 | 0.126 | Potassium channel (ATP-sensitive) blocker | |||
| 0.139 | 0.022 | 0.139 | Opioid delta receptor antagonist | |||
| 0.14 | 0.023 | 0.14 | Potassium channel activator | |||
| 0.128 | 0.011 | 0.128 | Carbonic anhydrase VB inhibitor | |||
| 0.128 | 0.011 | 0.128 | Acyl-CoA dehydrogenase inhibitor | 0.068 0.028 CID_154699703 | ||
| 0.129 | 0.013 | 0.129 | Dopamine uptake inhibitor | |||
| 0.12 | 0.004 | 0.12 | AMPA 4 receptor antagonist | |||
| 0.119 | 0.004 | 0.119 | MDM2 inhibitor | |||
| 0.163 | 0.048 | 0.163 | Neuropeptide Y1 antagonist | |||
| 0.171 | 0.056 | 0.171 | Cyclooxygenase inhibitor | |||
| 0.167 | 0.053 | 0.167 | MAO inhibitor | |||
| 0.128 | 0.014 | 0.128 | Carbamoyl phosphate synthetase inhibitor | 0.075 0.031 CID_154699703 | ||
| 0.118 | 0.004 | 0.118 | Glutamate (mGluR group III) antagonist | |||
| 0.142 | 0.028 | 0.142 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.217 | 0.105 | 0.352 | Interleukin agonist | 0.352 0.028 CID_154699703 | CID_154699703 | |
| 0.191 | 0.079 | 0.419 | Non-steroidal antiinflammatory agent | 0.419 0.011 CID_154699703 | CID_154699703 | |
| 0.152 | 0.04 | 0.152 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.125 | 0.014 | 0.125 | Carbonic anhydrase stimulant | |||
| 0.152 | 0.041 | 0.156 | Heat shock protein 70 antagonist | 0.156 0.033 CID_154699703 | CID_154699703 | |
| 0.179 | 0.068 | 0.179 | Tumour necrosis factor antagonist | |||
| 0.113 | 0.005 | 0.113 | Glutamate (mGluR4) antagonist | |||
| 0.126 | 0.018 | 0.126 | Aminopeptidase I inhibitor | |||
| 0.134 | 0.025 | 0.134 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.118 | 0.01 | 0.118 | Alpha 2 adrenoreceptor agonist | |||
| 0.114 | 0.006 | 0.114 | Melanocortin 5 agonist | |||
| 0.125 | 0.018 | 0.125 | Histamine H2 receptor antagonist | |||
| 0.135 | 0.029 | 0.135 | Catalase inhibitor | |||
| 0.121 | 0.015 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.112 | 0.006 | 0.112 | MAP kinase kinase 7 inhibitor | |||
| 0.111 | 0.005 | 0.111 | Sphingosine kinase inhibitor | |||
| 0.109 | 0.004 | 0.109 | Dihydroorotate oxidase inhibitor | |||
| 0.119 | 0.015 | 0.119 | Caspase 7 inhibitor | |||
| 0.137 | 0.034 | 0.137 | CDK/cyclin complex inhibitor | |||
| 0.118 | 0.015 | 0.118 | Carbonic anhydrase II inhibitor | 0.098 0.019 CID_154699703 | ||
| 0.108 | 0.006 | 0.108 | Phosphoglycerate kinase inhibitor | 0.05 0.014 CID_154699703 | ||
| 0.188 | 0.087 | 0.307 | DNA methylase inhibitor | 0.307 0.026 CID_154699703 | CID_154699703 | |
| 0.144 | 0.043 | 0.144 | MAO A inhibitor | |||
| 0.105 | 0.005 | 0.105 | Squalene epoxidase inhibitor | 0.053 0.029 CID_154699703 | ||
| 0.19 | 0.09 | 0.19 | Interleukin antagonist | |||
| 0.114 | 0.015 | 0.114 | TRPA1 antagonist | |||
| 0.14 | 0.04 | 0.412 | Expectorant | 0.412 0.005 CID_154699703 | CID_154699703 | |
| 0.142 | 0.042 | 0.193 | Microtubule formation inhibitor | 0.193 0.021 CID_154699703 | CID_154699703 | |
| 0.11 | 0.012 | 0.11 | NMDA receptor glycine site agonist | |||
| 0.112 | 0.013 | 0.112 | Purinergic P2X1 antagonist | 0.056 0.049 CID_154699703 | ||
| 0.117 | 0.019 | 0.117 | Estrogen receptor alpha antagonist | |||
| 0.101 | 0.005 | 0.101 | AICAR transformylase inhibitor | 0.046 0.027 CID_154699703 | ||
| 0.147 | 0.051 | 0.375 | Cyclooxygenase 3 inhibitor | 0.375 0.004 CID_154699703 | CID_154699703 | |
| 0.116 | 0.02 | 0.116 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 CID_154699703 | ||
| 0.1 | 0.005 | 0.1 | Potassium channel (Inward rectifier) activator | |||
| 0.109 | 0.013 | 0.109 | Xanthine dehydrogenase inhibitor | 0.05 0.046 CID_154699703 | ||
| 0.177 | 0.082 | 0.569 | Hepatoprotectant | 0.569 0.005 CID_154699703 | CID_154699703 | |
| 0.1 | 0.005 | 0.1 | Purinergic P2X4 antagonist | |||
| 0.117 | 0.022 | 0.117 | Bile acid receptor antagonist | |||
| 0.116 | 0.022 | 0.116 | Carbonic anhydrase V inhibitor | |||
| 0.127 | 0.033 | 0.127 | Opioid antagonist | |||
| 0.097 | 0.004 | 0.097 | Potassium channel (ATP-sensitive) activator | |||
| 0.117 | 0.024 | 0.117 | Glutathione S-transferase inhibitor | |||
| 0.108 | 0.017 | 0.108 | NMDA receptor agonist | |||
| 0.135 | 0.043 | 0.135 | MAO B inhibitor | |||
| 0.113 | 0.022 | 0.113 | Adenosine A2a receptor antagonist | |||
| 0.093 | 0.002 | 0.093 | Thyroid hormone alpha agonist | 0.016 0.013 CID_154699703 | ||
| 0.107 | 0.017 | 0.107 | Carbonic anhydrase I inhibitor | 0.096 0.019 CID_154699703 | ||
| 0.11 | 0.021 | 0.11 | Carbonic anhydrase VA inhibitor | |||
| 0.209 | 0.121 | 0.209 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.095 | 0.008 | 0.095 | Kainate receptor antagonist | |||
| 0.098 | 0.01 | 0.098 | Plasminogen activator inhibitor antagonist | |||
| 0.102 | 0.015 | 0.102 | GABA B receptor agonist | |||
| 0.138 | 0.051 | 0.138 | Cholesterol synthesis inhibitor | 0.1 0.087 CID_154699703 | ||
| 0.091 | 0.004 | 0.091 | Kainate receptor 5 antagonist | |||
| 0.113 | 0.027 | 0.113 | Opioid mu receptor antagonist | |||
| 0.09 | 0.003 | 0.09 | Heme oxygenase inhibitor | |||
| 0.116 | 0.03 | 0.116 | Alpha 2a adrenoreceptor antagonist | |||
| 0.213 | 0.128 | 0.213 | Lipoxygenase inhibitor | |||
| 0.129 | 0.045 | 0.129 | MAP kinase kinase kinase inhibitor | |||
| 0.095 | 0.011 | 0.095 | Phosphodiesterase 1A inhibitor | |||
| 0.136 | 0.053 | 0.136 | MAP kinase 12 inhibitor | |||
| 0.083 | 0.001 | 0.083 | Complement factor 1r inhibitor | 0.043 0.004 CID_154699703 | ||
| 0.088 | 0.006 | 0.088 | Fumarate hydratase inhibitor | 0.064 0.009 CID_154699703 | ||
| 0.153 | 0.071 | 0.153 | Acetylcholine M1 receptor antagonist | |||
| 0.094 | 0.013 | 0.094 | Cyclin B1 inhibitor | |||
| 0.096 | 0.015 | 0.113 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.113 0.012 CID_154699703 | CID_154699703 | |
| 0.091 | 0.01 | 0.091 | Aconitate hydratase inhibitor | |||
| 0.105 | 0.025 | 0.145 | Interferon agonist | 0.145 0.011 CID_154699703 | CID_154699703 | |
| 0.09 | 0.009 | 0.09 | Epithelial sodium channel blocker | 0.052 0.043 CID_154699703 | ||
| 0.192 | 0.111 | 0.407 | Vasodilator | 0.407 0.022 CID_154699703 | CID_154699703 | |
| 0.102 | 0.022 | 0.102 | Beta tubulin antagonist | |||
| 0.125 | 0.046 | 0.125 | Alpha 2c adrenoreceptor antagonist | |||
| 0.086 | 0.006 | 0.086 | Beta 2 adrenoreceptor agonist | |||
| 0.086 | 0.007 | 0.131 | Glucose-6-phosphate isomerase inhibitor | 0.131 0.003 CID_154699703 | CID_154699703 | |
| 0.082 | 0.004 | 0.082 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.089 | 0.012 | 0.089 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.099 | 0.023 | 0.099 | CC chemokine 5 receptor agonist | |||
| 0.146 | 0.07 | 0.311 | Cell wall synthesis inhibitor | 0.311 0.009 CID_154699703 | CID_154699703 | |
| 0.102 | 0.027 | 0.102 | Alpha adrenoreceptor agonist | |||
| 0.098 | 0.023 | 0.098 | CDK2/cyclin E inhibitor | |||
| 0.099 | 0.025 | 0.099 | HIV-1 integrase inhibitor | |||
| 0.081 | 0.007 | 0.081 | Thymidylate synthase inhibitor | |||
| 0.13 | 0.056 | 0.293 | Monophenol monooxygenase inhibitor | 0.293 0.018 CID_154699703 | CID_154699703 | |
| 0.122 | 0.049 | 0.122 | 5-Lipoxygenase inhibitor | |||
| 0.218 | 0.146 | 0.218 | Thyroid hormone antagonist | |||
| 0.106 | 0.033 | 0.106 | Vanilloid antagonist | |||
| 0.094 | 0.022 | 0.122 | Carbonic anhydrase IX inhibitor | 0.122 0.016 CID_154699703 | CID_154699703 | |
| 0.076 | 0.004 | 0.076 | Kainate receptor agonist | 0.044 0.023 CID_154699703 | ||
| 0.103 | 0.032 | 0.103 | Opioid kappa receptor antagonist | |||
| 0.085 | 0.014 | 0.085 | Cyclin D1 inhibitor | |||
| 0.232 | 0.162 | 0.232 | Calpain 2 inhibitor | |||
| 0.13 | 0.06 | 0.13 | Anesthetic local | |||
| 0.148 | 0.079 | 0.317 | Diuretic | 0.317 0.02 CID_154699703 | CID_154699703 | |
| 0.073 | 0.003 | 0.073 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.078 | 0.009 | 0.078 | Thymidine kinase inhibitor | 0.051 0.018 CID_154699703 | ||
| 0.09 | 0.022 | 0.09 | Argininosuccinate synthase inhibitor | 0.063 0.035 CID_154699703 | ||
| 0.087 | 0.019 | 0.114 | Interferon inducer | 0.114 0.009 CID_154699703 | CID_154699703 | |
| 0.094 | 0.025 | 0.094 | HIV-1 integrase (Strand Transfer) inhibitor | 0.051 0.049 CID_154699703 | ||
| 0.105 | 0.036 | 0.112 | Glutamate release inhibitor | 0.112 0.028 CID_154699703 | CID_154699703 | |
| 0.073 | 0.006 | 0.073 | Sigma 2 receptor antagonist | |||
| 0.077 | 0.01 | 0.077 | Ryanodine receptor antagonist | |||
| 0.13 | 0.063 | 0.13 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.07 | 0.005 | 0.07 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.087 | 0.022 | 0.087 | 5 Hydroxytryptamine 3 agonist | |||
| 0.07 | 0.005 | 0.07 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.099 | 0.034 | 0.099 | Vanilloid agonist | |||
| 0.1 | 0.036 | 0.1 | CYP2A6 inhibitor | |||
| 0.086 | 0.021 | 0.119 | Aldose reductase inhibitor | 0.119 0.014 CID_154699703 | CID_154699703 | |
| 0.076 | 0.013 | 0.222 | Alpha-mannosidase inhibitor | 0.222 0.003 CID_154699703 | CID_154699703 | |
| 0.068 | 0.005 | 0.068 | Catechol O-methyltransferase inhibitor | |||
| 0.092 | 0.03 | 0.092 | Adenosine A2 receptor antagonist | |||
| 0.067 | 0.005 | 0.067 | ATP citrate lysase inhibitor | |||
| 0.081 | 0.019 | 0.081 | Thromboxane antagonist | |||
| 0.096 | 0.035 | 0.096 | Cathepsin G inhibitor | |||
| 0.12 | 0.059 | 0.12 | TRPA1 agonist | |||
| 0.096 | 0.035 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.119 0.017 CID_154699703 | CID_154699703 | |
| 0.084 | 0.024 | 0.084 | 5 Hydroxytryptamine 2A agonist | |||
| 0.073 | 0.013 | 0.073 | Carbonic anhydrase IV inhibitor | |||
| 0.064 | 0.005 | 0.079 | Uridine phosphorylase inhibitor | 0.079 0.004 CID_154699703 | CID_154699703 | |
| 0.077 | 0.017 | 0.077 | Thromboxane A2 antagonist | |||
| 0.075 | 0.015 | 0.075 | Dopamine D2 agonist | |||
| 0.126 | 0.067 | 0.126 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.074 | 0.015 | 0.074 | Thromboxane synthase inhibitor | |||
| 0.106 | 0.047 | 0.172 | Uric acid excretion stimulant | 0.172 0.018 CID_154699703 | CID_154699703 | |
| 0.068 | 0.009 | 0.068 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.112 | 0.053 | 0.112 | Urease inhibitor | |||
| 0.065 | 0.007 | 0.065 | p53 inhibitor | |||
| 0.081 | 0.023 | 0.081 | Glutamate (mGluR6) antagonist | |||
| 0.065 | 0.006 | 0.065 | Beta adrenoreceptor agonist | |||
| 0.082 | 0.024 | 0.149 | Carbonic anhydrase XII inhibitor | 0.149 0.013 CID_154699703 | CID_154699703 | |
| 0.062 | 0.004 | 0.062 | Estrogen-related receptor beta antagonist | |||
| 0.134 | 0.076 | 0.134 | Aurora-C kinase inhibitor | |||
| 0.163 | 0.105 | 0.169 | Psychostimulant | 0.169 0.1 CID_154699703 | CID_154699703 | |
| 0.139 | 0.082 | 0.139 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.068 | 0.012 | 0.068 | CDK5/p25 inhibitor | |||
| 0.066 | 0.01 | 0.066 | Dopamine beta hydroxylase inhibitor | |||
| 0.065 | 0.01 | 0.065 | Nicotinic acid receptor agonist | |||
| 0.065 | 0.01 | 0.065 | GABA B receptor antagonist | |||
| 0.071 | 0.017 | 0.071 | Potassium channel (Inward rectifier) blocker | |||
| 0.102 | 0.047 | 0.102 | Alpha 2 adrenoreceptor antagonist | |||
| 0.121 | 0.067 | 0.237 | Alkylator | 0.237 0.018 CID_154699703 | CID_154699703 | |
| 0.127 | 0.073 | 0.127 | Cyclooxygenase 1 inhibitor | |||
| 0.064 | 0.01 | 0.064 | Geranyltranstransferase inhibitor | |||
| 0.13 | 0.076 | 0.135 | Alkaline phosphatase inhibitor | 0.135 0.071 CID_154699703 | CID_154699703 | |
| 0.063 | 0.009 | 0.063 | Membrane dipeptidase inhibitor | |||
| 0.058 | 0.004 | 0.058 | Thyroid hormone agonist | |||
| 0.132 | 0.079 | 0.132 | Neurotrophic factor | 0.118 0.098 CID_154699703 | ||
| 0.066 | 0.013 | 0.227 | Mannosidase inhibitor | 0.227 0.003 CID_154699703 | CID_154699703 | |
| 0.062 | 0.01 | 0.069 | Guanylate cyclase inhibitor | 0.069 0.005 CID_154699703 | CID_154699703 | |
| 0.091 | 0.039 | 0.091 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.09 | 0.038 | 0.09 | Transforming growth factor beta 3 antagonist | |||
| 0.103 | 0.051 | 0.103 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.054 | 0.004 | 0.054 | Nicotinic acid receptor 2 antagonist | |||
| 0.078 | 0.028 | 0.078 | Aromatase inhibitor | |||
| 0.088 | 0.039 | 0.088 | Analgesic, opioid | |||
| 0.097 | 0.047 | 0.097 | Ornithine decarboxylase inhibitor | |||
| 0.061 | 0.011 | 0.061 | Kainate receptor 2 antagonist | |||
| 0.128 | 0.078 | 0.128 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.054 | 0.004 | 0.054 | Thymidine phosphorylase inhibitor | 0.028 0.014 CID_154699703 | ||
| 0.054 | 0.005 | 0.054 | NMDA receptor glycine site antagonist | |||
| 0.073 | 0.024 | 0.073 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.075 | 0.027 | 0.075 | Acetylcholine M5 receptor antagonist | |||
| 0.061 | 0.013 | 0.061 | Benzodiazepine antagonist | |||
| 0.072 | 0.025 | 0.072 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 CID_154699703 | ||
| 0.052 | 0.005 | 0.052 | Kainate receptor 1 antagonist | |||
| 0.056 | 0.01 | 0.056 | RNA-directed RNA polymerase inhibitor | |||
| 0.082 | 0.036 | 0.495 | Selectin antagonist | 0.495 0.003 CID_154699703 | CID_154699703 | |
| 0.048 | 0.003 | 0.048 | Complement factor 1 inhibitor | |||
| 0.064 | 0.019 | 0.064 | Carbonic anhydrase II stimulant | |||
| 0.048 | 0.004 | 0.048 | Thyroid hormone alpha antagonist | |||
| 0.055 | 0.012 | 0.055 | Sphingosine kinase 1 inhibitor | |||
| 0.062 | 0.019 | 0.062 | CXC chemokine 1 receptor antagonist | |||
| 0.063 | 0.021 | 0.063 | Prolyl endopeptidase inhibitor | |||
| 0.049 | 0.007 | 0.049 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.054 | 0.011 | 0.054 | Melanocortin 3 agonist | |||
| 0.049 | 0.008 | 0.049 | Protein kinase (CK2) beta inhibitor | |||
| 0.064 | 0.023 | 0.064 | Pregnane X receptor antagonist | |||
| 0.05 | 0.009 | 0.05 | AMPA 3 receptor antagonist | |||
| 0.076 | 0.036 | 0.076 | CDK1/cyclin B inhibitor | |||
| 0.106 | 0.065 | 0.277 | Topoisomerase I inhibitor | 0.277 0.013 CID_154699703 | CID_154699703 | |
| 0.051 | 0.011 | 0.051 | Glutamate (mGluR8) agonist | |||
| 0.049 | 0.01 | 0.049 | HCV NS5B polymerase inhibitor | |||
| 0.078 | 0.038 | 0.078 | Neuronal nicotinic receptor antagonist | |||
| 0.07 | 0.031 | 0.07 | Transcription factor RelA inhibitor | |||
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | |||
| 0.042 | 0.004 | 0.042 | NMDA receptor phencyclidine site antagonist | |||
| 0.057 | 0.019 | 0.057 | Oxytocin agonist | |||
| 0.105 | 0.068 | 0.105 | Nav1.4 sodium channel blocker | |||
| 0.041 | 0.005 | 0.041 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.011 CID_154699703 | ||
| 0.06 | 0.023 | 0.242 | Heparanase inhibitor | 0.242 0.002 CID_154699703 | CID_154699703 | |
| 0.061 | 0.024 | 0.099 | Carbonic anhydrase XIV inhibitor | 0.099 0.011 CID_154699703 | CID_154699703 | |
| 0.057 | 0.02 | 0.057 | Adenylate cyclase 1 inhibitor | |||
| 0.051 | 0.015 | 0.051 | Alpha 1d adrenoreceptor agonist | |||
| 0.08 | 0.044 | 0.08 | Metalloproteinase-9 inhibitor | |||
| 0.043 | 0.008 | 0.131 | Sodium/glucose cotransporter 2 inhibitor | 0.131 0.002 CID_154699703 | CID_154699703 | |
| 0.121 | 0.085 | 0.121 | Bone formation stimulant | |||
| 0.068 | 0.033 | 0.068 | Acetylcholine M3 receptor antagonist | |||
| 0.039 | 0.003 | 0.039 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.059 | 0.024 | 0.059 | Vanilloid 2 antagonist | |||
| 0.119 | 0.085 | 0.119 | Toll-Like receptor antagonist | |||
| 0.039 | 0.005 | 0.039 | Beta 1 adrenoreceptor agonist | |||
| 0.059 | 0.025 | 0.188 | Phosphorylase inhibitor | 0.188 0.005 CID_154699703 | CID_154699703 | |
| 0.04 | 0.007 | 0.04 | MAP3K8 inhibitor | |||
| 0.067 | 0.034 | 0.067 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.052 | 0.019 | 0.052 | Leukotriene A4 hydrolase inhibitor | |||
| 0.077 | 0.044 | 0.077 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.037 | 0.004 | 0.037 | Alpha 2a adrenoreceptor agonist | |||
| 0.074 | 0.041 | 0.074 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.052 | 0.02 | 0.052 | Growth hormone release inhibitor | |||
| 0.058 | 0.026 | 0.058 | AMPA receptor antagonist | |||
| 0.054 | 0.022 | 0.054 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.036 | 0.004 | 0.036 | Complement factor 1s inhibitor | |||
| 0.11 | 0.08 | 0.11 | Cyclin-dependent kinase inhibitor | |||
| 0.047 | 0.018 | 0.047 | Glutamate (mGluR group II) antagonist | |||
| 0.109 | 0.08 | 0.109 | Acetylcholine muscarinic antagonist | |||
| 0.034 | 0.005 | 0.034 | Adenosine A3 receptor agonist | 0.019 0.009 CID_154699703 | ||
| 0.072 | 0.043 | 0.072 | Dopamine agonist | |||
| 0.039 | 0.01 | 0.039 | Kainate receptor 4 antagonist | |||
| 0.039 | 0.011 | 0.039 | Glutamate (mGluR3) agonist | |||
| 0.077 | 0.049 | 0.077 | Acetylcholine M4 receptor antagonist | |||
| 0.044 | 0.016 | 0.044 | CF transmembrane conductance regulator antagonist | |||
| 0.059 | 0.031 | 0.059 | Cannabinoid CB2 receptor antagonist | |||
| 0.062 | 0.035 | 0.062 | Botulinum neurotoxin type A inhibitor | |||
| 0.08 | 0.054 | 0.08 | Acetylcholine nicotinic antagonist | |||
| 0.066 | 0.04 | 0.066 | Dopamine D3 antagonist | |||
| 0.039 | 0.014 | 0.039 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.13 | 0.105 | 0.13 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.052 | 0.028 | 0.052 | Adenosine deaminase inhibitor | 0.048 0.032 CID_154699703 | ||
| 0.044 | 0.02 | 0.044 | TRPM8 blocker | |||
| 0.032 | 0.008 | 0.051 | Vanilloid 2 agonist | 0.051 0.003 CID_154699703 | CID_154699703 | |
| 0.087 | 0.064 | 0.087 | Pim-3 kinase inhibitor | |||
| 0.041 | 0.019 | 0.041 | Retinoid X alpha receptor agonist | |||
| 0.034 | 0.012 | 0.034 | 5 Hydroxytryptamine 6 agonist | |||
| 0.044 | 0.022 | 0.044 | Dihydropteroate synthase inhibitor | |||
| 0.064 | 0.042 | 0.064 | Acetylcholine M2 receptor antagonist | |||
| 0.032 | 0.01 | 0.127 | Sodium/glucose cotransporter inhibitor | 0.127 0.002 CID_154699703 | CID_154699703 | |
| 0.044 | 0.022 | 0.044 | Urate transporter 1 inhibitor | |||
| 0.052 | 0.03 | 0.052 | Topoisomerase II beta inhibitor | |||
| 0.038 | 0.016 | 0.038 | AMPA 1 receptor antagonist | |||
| 0.097 | 0.076 | 0.191 | DNA intercalator | 0.191 0.028 CID_154699703 | CID_154699703 | |
| 0.03 | 0.009 | 0.036 | Dopamine D1 agonist | 0.036 0.006 CID_154699703 | CID_154699703 | |
| 0.025 | 0.005 | 0.04 | Antibiotic Anthracycline-like | 0.04 0.002 CID_154699703 | CID_154699703 | |
| 0.056 | 0.035 | 0.056 | Immunoglobulin Fc receptor antagonist | |||
| 0.03 | 0.01 | 0.03 | Adenosine kinase inhibitor | |||
| 0.033 | 0.013 | 0.033 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.061 | 0.041 | 0.061 | Raf kinase C inhibitor | |||
| 0.056 | 0.036 | 0.056 | GABA receptor antagonist | |||
| 0.025 | 0.005 | 0.025 | Nicotinic acid receptor 1 antagonist | |||
| 0.028 | 0.009 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.063 | 0.044 | 0.063 | Kallikrein 7 inhibitor | |||
| 0.049 | 0.03 | 0.049 | Opioid mu receptor agonist | |||
| 0.11 | 0.091 | 0.11 | Cyclooxygenase 2 inhibitor | |||
| 0.027 | 0.009 | 0.027 | ICAM 1 antagonist | |||
| 0.035 | 0.016 | 0.035 | Cyclophilin A inhibitor | |||
| 0.067 | 0.049 | 0.067 | Exportin-1 inhibitor | |||
| 0.06 | 0.041 | 0.06 | Androgen agonist | |||
| 0.033 | 0.015 | 0.033 | Caspase 6 inhibitor | |||
| 0.02 | 0.002 | 0.02 | DNA topoisomerase III inhibitor | |||
| 0.045 | 0.027 | 0.045 | Dihydrofolate reductase inhibitor | |||
| 0.049 | 0.032 | 0.049 | Histamine H4 receptor antagonist | |||
| 0.13 | 0.113 | 0.13 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.023 | 0.006 | 0.023 | CXC chemokine 5 receptor antagonist | |||
| 0.091 | 0.074 | 0.091 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.031 | 0.015 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.059 | 0.043 | 0.059 | Bcl-xL inhibitor | |||
| 0.021 | 0.004 | 0.021 | Carbonic anhydrase XI inhibitor | |||
| 0.098 | 0.081 | 0.098 | Protein kinase C gamma inhibitor | |||
| 0.03 | 0.013 | 0.03 | Glucosylceramidase stimulant | |||
| 0.081 | 0.065 | 0.081 | mTOR complex 2 inhibitor | |||
| 0.037 | 0.022 | 0.037 | Opioid delta receptor agonist | |||
| 0.047 | 0.032 | 0.047 | Carbonic anhydrase VII inhibitor | |||
| 0.053 | 0.038 | 0.053 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.022 | 0.007 | 0.022 | Estrogen-related receptor gamma agonist | |||
| 0.019 | 0.004 | 0.019 | Integrin beta6 antagonist | |||
| 0.024 | 0.01 | 0.024 | Imidazoline I1 receptor antagonist | |||
| 0.031 | 0.016 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.02 CID_154699703 | ||
| 0.054 | 0.04 | 0.054 | Ribonucleotide reductase inhibitor | |||
| 0.031 | 0.017 | 0.031 | Melanocortin 1 agonist | |||
| 0.027 | 0.013 | 0.028 | Adenosine A1 receptor agonist | 0.028 0.013 CID_154699703 | CID_154699703 | |
| 0.021 | 0.007 | 0.029 | Telomerase stimulant | 0.029 0.003 CID_154699703 | CID_154699703 | |
| 0.069 | 0.055 | 0.069 | Phospholipase D inhibitor | |||
| 0.047 | 0.033 | 0.047 | Potassium channel Kv1.3 blocker | |||
| 0.072 | 0.058 | 0.072 | Vanilloid 4 agonist | |||
| 0.052 | 0.039 | 0.052 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.021 | 0.008 | 0.021 | Adenosine A2 receptor agonist | 0.016 0.012 CID_154699703 | ||
| 0.02 | 0.008 | 0.02 | Adenosine A2a receptor agonist | |||
| 0.148 | 0.136 | 0.148 | Insulin sensitizer | |||
| 0.033 | 0.021 | 0.033 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.017 | 0.005 | 0.017 | Beta 3 adrenoreceptor agonist | |||
| 0.125 | 0.113 | 0.125 | Pregnane X receptor agonist | |||
| 0.046 | 0.034 | 0.046 | Urokinase inhibitor | |||
| 0.055 | 0.044 | 0.055 | Cathepsin L inhibitor | |||
| 0.015 | 0.004 | 0.015 | Thyroid hormone beta agonist | |||
| 0.034 | 0.022 | 0.034 | Melatonin receptor 1A agonist | |||
| 0.033 | 0.022 | 0.033 | Dipeptidyl peptidase II inhibitor | |||
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.02 | 0.009 | 0.02 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.051 | 0.04 | 0.051 | GABA A receptor antagonist | |||
| 0.049 | 0.039 | 0.049 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.063 | 0.053 | 0.063 | Sirtuin 1 inhibitor | |||
| 0.03 | 0.02 | 0.03 | Glutamate (mGluR2) antagonist | |||
| 0.021 | 0.011 | 0.021 | Caspase 8 inhibitor | |||
| 0.023 | 0.014 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.047 | 0.038 | 0.047 | Adenosine A2b receptor antagonist | |||
| 0.054 | 0.046 | 0.054 | Leukotriene C antagonist | |||
| 0.1 | 0.092 | 0.1 | Acetylcholine antagonist | |||
| 0.101 | 0.094 | 0.101 | Cholinergic antagonist | |||
| 0.052 | 0.045 | 0.052 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.036 | 0.029 | 0.036 | Somatostatin 1 antagonist | |||
| 0.029 | 0.022 | 0.029 | AMPA 2 receptor antagonist | |||
| 0.012 | 0.005 | 0.019 | Purinergic P2Y2 agonist | 0.019 0.002 CID_154699703 | CID_154699703 | |
| 0.016 | 0.009 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.034 | 0.028 | 0.034 | Histone deacetylase 7 inhibitor | |||
| 0.192 | 0.186 | 0.192 | Vasodilator, peripheral | |||
| 0.065 | 0.059 | 0.065 | Dopamine antagonist | |||
| 0.056 | 0.05 | 0.056 | Cannabinoid CB1 receptor antagonist | |||
| 0.013 | 0.007 | 0.013 | Purine nucleoside phosphorylase inhibitor | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.019 | 0.014 | 0.019 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.048 | 0.043 | 0.048 | Histamine agonist | |||
| 0.015 | 0.01 | 0.015 | Egl nine homolog 1 inhibitor | |||
| 0.015 | 0.01 | 0.015 | Adenosine A2b receptor agonist | |||
| 0.022 | 0.017 | 0.022 | Isoleucine-tRNA ligase inhibitor | |||
| 0.064 | 0.06 | 0.064 | Protein kinase C beta inhibitor | |||
| 0.031 | 0.026 | 0.031 | Melatonin 2 agonist | |||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.032 | 0.028 | 0.032 | Retinoid X receptor agonist | |||
| 0.037 | 0.033 | 0.037 | Histone deacetylase 8 inhibitor | |||
| 0.036 | 0.032 | 0.036 | GABA uptake inhibitor | |||
| 0.084 | 0.08 | 0.084 | Sphingomyelinase inhibitor | |||
| 0.164 | 0.16 | 0.436 | Peptidyltransferase inhibitor | 0.436 0.005 CID_154699703 | CID_154699703 | |
| 0.018 | 0.014 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.066 | 0.063 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.046 | 0.043 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.087 | 0.084 | 0.087 | Falcipain 3 inhibitor | |||
| 0.024 | 0.022 | 0.024 | Urotensin II agonist | |||
| 0.032 | 0.03 | 0.063 | Arginase inhibitor | 0.063 0.009 CID_154699703 | CID_154699703 | |
| 0.024 | 0.022 | 0.024 | CXC chemokine 2 receptor antagonist | |||
| 0.052 | 0.05 | 0.076 | Adenine nucleotide translocase inhibitor | 0.076 0.011 CID_154699703 | CID_154699703 | |
| 0.016 | 0.014 | 0.016 | Kainate receptor 3 antagonist | |||
| 0.046 | 0.044 | 0.046 | CD45 antagonist | |||
| 0.111 | 0.109 | 0.111 | Activin receptor-like kinase 2 inhibitor | |||
| 0.218 | 0.216 | 0.218 | Analgesic | |||
| 0.033 | 0.031 | 0.033 | 5-Alpha-reductase inhibitor | |||
| 0.029 | 0.028 | 0.029 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.02 | 0.019 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.026 | 0.025 | 0.026 | CDK4/cyclin D3 inhibitor | |||
| 0.019 | 0.018 | 0.019 | Estrone sulfatase inhibitor | |||
| 0.012 | 0.011 | 0.012 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.002 | 0.003 | 0.004 | Purinergic P2Y6 agonist | 0.004 0.002 CID_154699703 | CID_154699703 | |
| 0.024 | 0.026 | 0.045 | Toll-Like receptor 4 agonist | 0.045 0.004 CID_154699703 | CID_154699703 | |
| 0.085 | 0.091 | 0.123 | Phosphodiesterase 6D inhibitor | 0.123 0.022 CID_154699703 | CID_154699703 | |
| 0.085 | 0.096 | 0.263 | AMP-activated protein kinase stimulant | 0.263 0.006 CID_154699703 | CID_154699703 | |
| 0.045 | 0.057 | 0.06 | Leukotriene B4 antagonist | 0.06 0.027 CID_154699703 | CID_154699703 | |
| 0.01 | 0.027 | 0.029 | Ileal bile acid transport inhibitor | 0.029 0.005 CID_154699703 | CID_154699703 | |
| 0.023 | 0.041 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_154699703 | CID_154699703 | |
| 0.006 | 0.024 | 0.011 | Purinergic P2Y agonist | 0.011 0.01 CID_154699703 | CID_154699703 | |
| 0.006 | 0.025 | 0.015 | Purinergic receptor agonist | 0.015 0.011 CID_154699703 | CID_154699703 | |
| 0.006 | 0.025 | 0.015 | Purinergic P2 agonist | 0.015 0.011 CID_154699703 | CID_154699703 | |
| 0.017 | 0.035 | 0.079 | Protein 30S ribosomal subunit inhibitor | 0.079 0.004 CID_154699703 | CID_154699703 | |
| 0.091 | 0.112 | 0.099 | Acetylcholine release stimulant | 0.099 0.09 CID_154699703 | CID_154699703 | |
| 0.117 | 0.14 | 0.454 | Nitric oxide antagonist | 0.454 0.02 CID_154699703 | CID_154699703 | |
| 0.187 | 0.213 | 0.462 | Interleukin 2 agonist | 0.462 0.013 CID_154699703 | CID_154699703 | |
| 0.115 | 0.153 | 0.204 | DNA methyltransferase I inhibitor | 0.204 0.067 CID_154699703 | CID_154699703 | |
| 0.068 | 0.11 | 0.167 | Mediator release inhibitor | 0.167 0.022 CID_154699703 | CID_154699703 | |
| 0.048 | 0.092 | 0.121 | Neuraminidase (influenza) inhibitor | 0.121 0.012 CID_154699703 | CID_154699703 | |
| 0.036 | 0.086 | 0.048 | Cytokine production stimulant | 0.048 0.034 CID_154699703 | CID_154699703 | |
| 0.038 | 0.09 | 0.056 | Factor III inhibitor | 0.056 0.022 CID_154699703 | CID_154699703 | |
| 0.102 | 0.157 | 0.329 | NOS3 expression enhancer | 0.329 0.014 CID_154699703 | CID_154699703 | |
| 0.045 | 0.11 | 0.072 | Lipocortins synthesis agonist | 0.072 0.019 CID_154699703 | CID_154699703 | |
| 0.037 | 0.105 | 0.257 | Antineoplastic antibiotic | 0.257 0.013 CID_154699703 | CID_154699703 | |
| 0.009 | 0.09 | 0.021 | Corticosteroid-like | 0.021 0.016 CID_154699703 | CID_154699703 | |
| 0.097 | 0.179 | 0.366 | Hemostatic | 0.366 0.01 CID_154699703 | CID_154699703 | |
| 0.06 | 0.144 | 0.258 | Topoisomerase II inhibitor | 0.258 0.023 CID_154699703 | CID_154699703 | |
| 0.032 | 0.116 | 0.108 | Glucose-6-phosphate translocase inhibitor | 0.108 0.005 CID_154699703 | CID_154699703 | |
| 0.063 | 0.154 | 0.14 | DNA polymerase I inhibitor | 0.14 0.055 CID_154699703 | CID_154699703 | |
| 0.007 | 0.105 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.012 CID_154699703 | CID_154699703 | |
| 0.124 | 0.227 | 0.717 | Hypoglycemic | 0.717 0.005 CID_154699703 | CID_154699703 | |
| 0.038 | 0.144 | 0.157 | Topoisomerase II alpha inhibitor | 0.157 0.022 CID_154699703 | CID_154699703 | |
| 0.064 | 0.174 | 0.178 | Toll-Like receptor 4 antagonist | 0.178 0.01 CID_154699703 | CID_154699703 | |
| 0.062 | 0.178 | 0.116 | Multidrug resistance-associated protein 1 inhibitor | 0.116 0.053 CID_154699703 | CID_154699703 | |
| 0.017 | 0.141 | 0.056 | Prostaglandin EP2 antagonist | 0.056 0.045 CID_154699703 | CID_154699703 | |
| 0.007 | 0.137 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.009 CID_154699703 | CID_154699703 | |
| 0.02 | 0.153 | 0.096 | Neuraminidase inhibitor | 0.096 0.017 CID_154699703 | CID_154699703 | |
| 0.03 | 0.163 | 0.058 | Transcription factor AP-1 inhibitor | 0.058 0.049 CID_154699703 | CID_154699703 | |
| 0.018 | 0.191 | 0.094 | Antibiotic Aminoglycoside-like | 0.094 0.003 CID_154699703 | CID_154699703 | |
| 0.005 | 0.187 | 0.049 | Squalene synthetase inhibitor | 0.049 0.015 CID_154699703 | CID_154699703 | |
| 0.098 | 0.305 | 0.152 | CC chemokine 6 receptor antagonist | 0.152 0.019 CID_154699703 | CID_154699703 | |
| 0.001 | 0.265 | 0.016 | Antibiotic Macrolide-like | 0.016 0.009 CID_154699703 | CID_154699703 | |
| 0.078 | 0.366 | 0.239 | Alpha-glucosidase inhibitor | 0.239 0.194 CID_154699703 | CID_154699703 | |
| 0.013 | 0.314 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 CID_154699703 | CID_154699703 | |
| 0.051 | 0.371 | 0.445 | Platelet adhesion inhibitor | 0.445 0.008 CID_154699703 | CID_154699703 | |
| 0.04 | 0.367 | 0.166 | Transcription factor NF kappa B stimulant | 0.166 0.013 CID_154699703 | CID_154699703 | |
| 0.019 | 0.408 | 0.08 | Histone deacetylase stimulant | 0.08 0.044 CID_154699703 | CID_154699703 | |
| 0.019 | 0.408 | 0.08 | Histone deacetylase SIRT1 stimulant | 0.08 0.044 CID_154699703 | CID_154699703 | |
| 0.093 | 0.494 | 0.832 | Cyclophilin D inhibitor | 0.832 0.005 CID_154699703 | CID_154699703 | |
| 0.008 | 0.417 | 0.048 | Microtubule stabilization | 0.048 0.03 CID_154699703 | CID_154699703 | |
| 0.01 | 0.468 | 0.13 | Protein 50S ribosomal subunit inhibitor | 0.13 0.008 CID_154699703 | CID_154699703 | |
| 0.042 | 0.536 | 0.268 | Angiogenesis inhibitor | 0.268 0.111 CID_154699703 | CID_154699703 | |
| 0.066 | 0.568 | 0.223 | Caspase 3 stimulant | 0.223 0.139 CID_154699703 | CID_154699703 | |
| 0.021 | 0.547 | 0.294 | Hypolipemic | 0.294 0.051 CID_154699703 | CID_154699703 | |
| 0.014 | 0.635 | 0.34 | Thrombolytic | 0.34 0.018 CID_154699703 | CID_154699703 | |
| 0.022 | 0.721 | 0.502 | Immunosuppressant | 0.502 0.033 CID_154699703 | CID_154699703 | |
| 0.012 | 0.763 | 0.097 | Factor IXa inhibitor | 0.097 0.01 CID_154699703 | CID_154699703 | |
| 0.012 | 0.769 | 0.407 | Tumour necrosis factor alpha release inhibitor | 0.407 0.026 CID_154699703 | CID_154699703 | |
| 0.007 | 0.767 | 0.263 | Anticoagulant | 0.263 0.036 CID_154699703 | CID_154699703 | |
| 0.01 | 0.785 | 0.296 | Cell adhesion inhibitor | 0.296 0.01 CID_154699703 | CID_154699703 | |
| 0.01 | 0.819 | 0.177 | Interleukin 6 antagonist | 0.177 0.057 CID_154699703 | CID_154699703 | |
| 0.005 | 0.87 | 0.286 | Platelet antagonist | 0.286 0.058 CID_154699703 | CID_154699703 | |
| 0.004 | 0.874 | 0.058 | Nitric oxide donor | 0.058 0.051 CID_154699703 | CID_154699703 | |
| 0.009 | 0.911 | 0.412 | Immunomodulator | 0.412 0.04 CID_154699703 | CID_154699703 | |
| 0.006 | 0.935 | 0.222 | Insulin secretagoues | 0.222 0.026 CID_154699703 | CID_154699703 | |
| 0.011 | 0.941 | 0.082 | T cell inhibitor | 0.082 0.058 CID_154699703 | CID_154699703 | |
| 0.004 | 0.971 | 0.11 | Cell adhesion molecule inhibitor | 0.11 0.029 CID_154699703 | CID_154699703 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |